🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsMASH / Liver DiseaseNon-invasive MASH biomarkers — March 2026 Page 11

Non-invasive MASH biomarkers — March 2026

AttorneyGrant Thu, Feb 8, 2024 at 1:03 AM 54 replies 3,138 viewsPage 11 of 11
B12Beth
Member
289
890
Oct 2024
Maryland
Feb 6, 2025 at 8:34 PM#51
Dr.PeteFamMed said:
Practical: whatever you change, write down the date and the reason.

Worth saying that the confident version of this is more useful to the person writing it than to the person reading it.

Ask again with the specifics and you will get a better answer than this one.

Last edited: Feb 6, 2025 at 11:34 PM
16 14GraceAZ_72, carl_compliance, DanielChem_CHI and 13 others
Reply Quote Save Share Report
wei_SG
Member
234
890
Nov 2024
Singapore, SG
Feb 17, 2025 at 8:03 PM#52
Dr.PeteFamMed said:
Practical: whatever you change, write down the date and the reason.

No disagreement, though the timescale matters more than the mechanism here. Most of what looks like a difference in kind turns out to be a difference in how long somebody waited.

If somebody has the primary source to hand I would rather cite it than paraphrase it.

17 15SaraMom3, Dr.MetabolicMD, RetaRick_CA and 14 others
Reply Quote Save Share Report
SkepticalSean
Member
98
345
Jan 2025
Maine
Feb 28, 2025 at 7:25 PM#53
Dr.PeteFamMed said:
Practical: whatever you change, write down the date and the reason.

Thank you — that is the clearest version of this I have read, and I have read a lot of them.

18 16emma_london, tammy_FL, Dr.LipidDallas and 15 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
Dr.BariatricHTX
Senior Member
1,456
7,234
Feb 2024
Houston, TX
Mar 11, 2025 at 6:41 PM#54

From the other side of the consultation, briefly. The mechanism and the magnitude are separate questions. Agreeing that something happens says nothing about whether it happens enough to act on.

Last edited: Mar 12, 2025 at 12:41 AM
19 17stefan_berlin, Dr.EM_Chicago, pete_RVA and 16 others
Reply Quote Save Share Report
marco_milano
Member
345
1,456
Jul 2024
Milan, IT
Mar 22, 2025 at 5:51 PM#55

Old thread, but it comes up first when you search for this, so it is worth updating. One habit that pays for itself: post the method alongside the number. A figure without its method cannot be checked, and an unchecked figure is how this community accumulates folklore.

20 18emma_london, tammy_FL, Dr.LipidDallas and 17 others
Reply Quote Save Share Report

Similar Threads

Survodutide MASH Phase 2b — histological improvement data9 replies
Semaglutide and MASH — liver fat reduction quantification13 replies
Non-invasive MASH biomarkers — FibroScan, ELF, FIB-4 on GLP-110 replies
ALT normalization rates on GLP-1 — pooled trial data20 replies
GLP-1 hepatoprotection — direct vs indirect mechanisms16 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register